+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia-Pacific Defibrillators Market 2019-2025

  • PDF Icon


  • January 2020
  • Region: Asia Pacific
  • Orion Market Research Private Limited
  • ID: 4969080
The Asia-Pacific market is considered to be one of the emerging market due to huge population of CVD, CHD, stroke and other heart diseases and is growing at a modest rate due to various factors such as the rising healthcare spending, improving infrastructure and economy, and rising standards of living. Improving healthcare system, prevalence of huge CVD, stroke, and heart patients and investment from private players are expected to drive the market in upcoming years. The APAC drugs market is predicted to contribute highest in the growth of cardiology market followed by device market due to huge adoption of cardiology drugs, high cost of drugs, and favorable government policies. APAC region includes China, India, Japan, Korea, Taiwan and other regions, which contribute significantly to the growth of cardiology market due to rising heart patients, government policies and adoption of robotic surgeries.

The region is expected to grow significantly in the healthcare domain and particularly, there is huge advancement in the defibrillator market. The adoption of innovative devices and technological advancement created huge scope in the market. India, China, and Japan are medical tourism places for various countries due to cheaper surgery rates and treatment costs. Patients travel huge distances to get quality treatment at economical prices. The demand for implanted surgeries and devices is rising in the region due to medical tourism and rising heart patients across the region.

Geriatric population is also one of the major concerns for the Japanese government and other healthcare institution. For instance, in Japan, out of total 126 million population, about 27% population of the country was above 65 years in 2017. It is forecast that the population will reduce to 123 million in 2023 and geriatric population is forecast to be higher as compared to 2017. The incidence of heart stroke occurrence in geriatric population is relatively high as compared to young population. As per the Institute for Health Metrics and Evaluation, in 2017, around 0.2 million incidences of ischemic heart disease occurred in Japan. The prevalence of Ischemic heart disease in 2013 was 3.5 million peoples that have increased to 3.7 million in 2017, that contributes to the market growth.

Research Methodology

The market study of the Asia-Pacific Defibrillators market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors.

Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for medical device manufacturing companies, distributors and suppliers, and other related companies for overall market analysis and competitive analysis. The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Asia-Pacific Defibrillators Market Research and Analysis by Type
2. Asia-Pacific Defibrillators Market Research and Analysis by End-users

The Report Covers
  • Comprehensive research methodology of the Asia-Pacific Defibrillators market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the Asia-Pacific Defibrillators market.
  • Insights about market determinants which are stimulating the Asia-Pacific Defibrillators market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Asia-Pacific Defibrillators Market by Type
5.1.1. Implantable Cardioverter Defibrillators
5.1.2. External Cardioverter Defibrillators
5.2. Asia-Pacific Defibrillators Market by End-Users
5.2.1. Hospitals
5.2.2. Ambulatory Services and Others
6. Regional Analysis
6.1. China
6.2. India
6.3. Japan
6.4. Rest of Asia-Pacific
7. Company Profiles
7.1. Abbott Laboratories, Inc.
7.2. Biotronik SE & Co. KG
7.3. Cintas Corp.
7.4. Defibtech LLC
7.5. General Electric Co.
7.6. Koninklijke Philips N.V.
7.7. LivaNova PLC
7.8. Medtronic PLC
7.9. Mindray Medical International Co. Ltd.
7.10. Nihon Kohden Corp.
7.11. Stryker Corp.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories, Inc.
  • Biotronik SE & Co. KG
  • Cintas Corp.
  • Defibtech LLC
  • General Electric Co.
  • Koninklijke Philips N.V.
  • LivaNova PLC
  • Medtronic PLC
  • Mindray Medical International Co. Ltd.
  • Nihon Kohden Corp.
  • Stryker Corp.